CASE REPORT |
|
Year : 2019 | Volume
: 10
| Issue : 2 | Page : 155-158 |
|
Primary plasma cell leukemia in a 55-year-old Nigerian woman
Theresa Ukamaka Nwagha1, Alozie Uchenna Eze2, Richard Chidubem Okebaram2, Helen Chioma Okoye1
1 Department of Haematology and Immunology, University of Nigeria Teaching Hospital; Department of Haematology and Immunology, College of Medicine, University of Nigeria, Ituku-Ozalla Campus, Enugu, Nigeria 2 Department of Haematology and Immunology, University of Nigeria Teaching Hospital, Enugu, Nigeria
Correspondence Address:
Dr. Helen Chioma Okoye Department of Haematology and Immunology, College of Medicine, University of Nigeria, Ituku-Ozalla Campus, Enugu Nigeria
Source of Support: None, Conflict of Interest: None
DOI: 10.4103/atp.atp_5_19
|
|
Plasma cell leukemia (PCL) is a rare and an aggressive disease, accounting for only 2%–3% of all plasma cell dyscrasias. Diagnosis is made by the presence of more than 2 × 109/L plasma cells in the peripheral blood or monoclonal plasmacytosis more than 20% of the plasma cells in the peripheral blood. PCL has limited treatment options comprising of the conventional multiple myeloma (MM) treatment drugs and a very poor prognosis. We report a case of a 55-year-old woman who presented with a history of high-grade fever, generalized weakness, petechial rashes, and transfusion-dependent anemia of about 3 months' duration. Peripheral blood film revealed moderate leukocytosis with 30% plasma cells. Bone marrow aspirate also showed significant plasmacytosis. Immunophenotyping confirmed peripheral blood plasmacytosis. The patient initially responded to chemotherapy but succumbed to the disease. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|